Tag: Johnson & Johnson
May 14, 2019
5 Top Pharmaceutical ETFs
A wide range of investors may want to consider pharmaceutical ETFs as a way to stay informed about and invest...
April 18, 2019
Pharma Market Update: Q1 2019 in Review
With Q1 2019 officially over, the Investing News Network shares a pharma market update on the biggest news and trends...
March 6, 2019
FDA Approves Johnson & Johnson’s Nasal Spray Antidepressant
Spravato, which is administered via a nasal spray, is the first FDA-approved antidepressant in over 30 years.
February 26, 2019
Senate Finance Committee Blasts Pharma CEOs on Drug Prices
This was the largest panel of pharmaceutical executives "in decades" to appear before a congressional committee.
December 26, 2018
5 Top Genetics News Stories of 2018
What caught the attention of readers in the genetics market this year? We've compiled a list of our top genetics...
October 24, 2018
Zymeworks Makes First Dermatology Licensing Deal
This is the first joint antibody discovery and development collaboration for Zymeworks and marks the first dermatology-specific partnership for the...
October 16, 2018